Compare AU

Compare DRUG vs. RCB

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Russell Investments Australian Select Corporate Bond ETF (RCB). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

RCB

Popularity

Low

Low

Pearlers invested

63

9

Median incremental investment

$990.50

$1,200.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,928.85

$4,397.06

Average age group

26 - 35

> 35


Key Summary

DRUG

RCB

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

RCB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide a total return before costs and tax, in line with DBIQ 0-4 year Investment Grade Australian Corporate Bond Index over the long term

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Westpac Banking Corp. 5% (14.25 %)

National Australia Bank Ltd. 4.95% (13.06 %)

Commonwealth Bank of Australia 4.9% (11.68 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.28 %


Key Summary

DRUG

RCB

Issuer

BetaShares

Russell

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

DBIQ 0-4 year Investment Grade Australian Corporate Bond Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.28 %

Price

$8.35

$20.17

Size

$182.401 million

$283.625 million

10Y return

N/A

-1.71 %

Annual distribution yield (5Y)

1.90 %

2.22 %

Market

ASX

ASX

First listed date

08/08/2016

13/03/2012

Purchase fee

$6.50

$6.50


Community Stats

DRUG

RCB

Popularity

Low

Low

Pearlers invested

63

9

Median incremental investment

$990.50

$1,200.00

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,928.85

$4,397.06

Average age group

26 - 35

> 35


Pros and Cons

DRUG

RCB

Pros

  • Higher exposure to US market

  • Higher price growth

  • Lower management fee

  • Higher distribution yield

Cons

  • Higher management fee

  • Lower distribution yield

  • Lower exposure to US market

  • Lower price growth

DRUG

RCB

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home